Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A15448 | Pages: NA | Charts: NA | Tables: NA |
Image-guided biopsy uses imaging technologies to examine the inside of the body. The biopsy allows the medical expert to readily obtain a sample of the suspicious cell by inserting the needle into the optimum position. It is regarded as one of the greatest methods of collecting samples because it produces no significant harm. As pictures are required to guide the placement of the needle during a biopsy, this technique is often performed in one of the two locations, such as in the Interventional Radiology (IR) suite using ultrasound (sound waves) or fluoroscopy (X-rays), or in the CT room with a CT scanner.
COVID-19 Impact Analysis
Globally, the COVID-19 pandemic has impacted routine hospital services. Elective procedures are being reduced significantly in order to reduce the risk of infection and to transform operating rooms into COVID-19 emergency facilities. The vast majority of participants cancelled planned appointments, routine check-ups, or chronic condition treatment. To resume elective procedures, various safety standards must be followed, such as maintaining sanitation, isolating patients before and after surgery, and testing patients for COVID-19 before they are admitted for the surgery. Delaying routine or preventative screenings was acceptable during the pandemic's beginning stage, especially with patients using efficient telemedicine services. As a result, COVID-19 is expected to have a substantial impact on the image-guided biopsy market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish Image-guided Biopsy Market
In January 2019, IZI Medical Products acquired Cook Medical’s soft tissue biopsy and breast localization needle product line.
In February 2018, Merit Medical Systems, Inc. announced the closure of its purchase of divestment assets from BD (Becton, Dickinson, and Company).
In September 2018, EZ Shot 3 Plus 25 G EUS single-use needle, developed by Olympus Corporation for fine-needle biopsy and aspiration, received a FDA approval. The needle can be used to study submucosal and extramural lesions found in various sections of the gastrointestinal tract. Merit Medical Systems Inc. launched five new manual bone biopsy systems for upper-spine, deep-bone, and narrow-access procedures in the same month.
The rise in incidences of cancer is the most important factor to drive the growth of the image-guided biopsy market. According to the World Health Organization (WHO), 21.4 million more patients will be diagnosed with malignant tumors in 2030, up from 12.7 million in 2008. Furthermore, cancer took the lives of 9.6 million people globally in 2018. Biopsy and aspiration are commonly used to explore the nature of tumors by removing a portion of the tissue or fluid in concern and analyze it. With the rising cancer burden, healthcare professionals and government agencies are stepping up efforts to deliver improved diagnostic services, leading to an increase in demand for the image-guided biopsy market.
Key Benefits of Report
Questions Answered in Image-Guided Biopsy Market Report
Key Market Segments
Key Market Players